To assess the therapeutic effect in a given mouse tumor model, a qualitative analysis of tumor-specific CD8+ T cell responses provides a digital measurement critical for anti-tumor immunity; however, tumor-specific CD8+ T cell responses were not assessed in any of the aforementioned tumor models, possibly because most endogenous TAs were not defined with respect to the generation of their respective Abs. This evidence concerns the gene CD8A and neoplasm.